In partnership with the Health Care Cost Institute (HCCI) in the United States, and iFHP member companies in multiple countries, iFHP has published the latest International Health Cost Comparison Report.
The expanded report compares the cost of a selection of inpatient treatments, outpatient treatments and prescribed drugs as reported by iFHP members in eleven countries in 2019.
Data in the report demonstrate that where you live continues to have an enormous influence on the cost of your healthcare. Several types of care may be up to ten times more expensive in some countries over others that are otherwise geographically, politically, and economically similar.
“While healthcare in the United States is commonly thought to be among the most expensive in the world, this latest report suggests this may no longer be true for all health costs,” said Chris Watney, CEO of iFHP. “Although international comparisons need to be made carefully, it’s our hope that strategies employed to challenge the status quo on drug pricing and some outpatient procedures are starting to bring some median US costs in line with, or better than international benchmarks.”